Daniell Richard
Reporting owner on Forms 3, 4 and 5, CIK 1726096.
Daniell Richard reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| TEVA · TEVA PHARMACEUTICAL INDUSTRIES LTDCIK 818686 | officer (EVP, Europe Commercial) | 1 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| TEVA · TEVA PHARMACEUTICAL INDUSTR…Ordinary Shares | 2026-11-11 | M exercised | +20,003 | $34.7 | 75,758 | Form 4 |
| TEVA · TEVA PHARMACEUTICAL INDUSTR…Ordinary Shares | 2026-11-11 | S sold | -20,003 | $42.8013 | 55,755 | Form 4 |
| TEVA · TEVA PHARMACEUTICAL INDUSTR…Stock Options (right to buy), derivative | 2026-11-11 | M exercised | -20,003 | $0 | 0 | Form 4 |
| TEVA · TEVA PHARMACEUTICAL INDUSTR…Ordinary Shares | 2026-11-09 | M exercised | +25,000 | $34.7 | 80,755 | Form 4 |
| TEVA · TEVA PHARMACEUTICAL INDUSTR…Ordinary Shares | 2026-11-09 | S sold | -25,000 | $42.9116 | 55,755 | Form 4 |
| TEVA · TEVA PHARMACEUTICAL INDUSTR…Stock Options (right to buy), derivative | 2026-11-09 | M exercised | -25,000 | $0 | 20,003 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-458451 | TEVA PHARMACEUTICAL INDUSTRIES LTD | 2026-11-12 |